Findings identify immunological biomarkers in major depressive disorder, suggesting potential therapeutic targets.
Our findings contribute to the understanding of the relationship between MDD and immune infiltration. DACH1, FZD7, and GULP1 may be key biomarkers and potential therapeutic targets for MDD.
No takes yet. Share an insight, caveat, or question.
Kangsheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: